ArticleGynecologic oncology reports2020

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma.

Silvia Pelligra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.